Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Synthelabo investigates oxazolidinones

Jan. 30, 1997

N-oxide antibacterial compounds from Bayer

Jan. 30, 1997

New cephem antibacterial agents from Takeda

Jan. 30, 1997

Schering-Plough claims tetrahydrofuran antifungal agents

Jan. 30, 1997

Voriconazole effective in guinea pig model of A. fumigatus endocarditis

Jan. 28, 1997

Mediolanum prepares novel quinolone antibacterial agents

Jan. 28, 1997

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Roche presents new antifungal agents

Jan. 24, 1997

Antifungal echinocandin derivatives reported by Lilly

Jan. 24, 1997

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...